GlassScriptPhysician profile
Steven M Liebowitz
NPI 1386646453
$4,448.54
in general payments reported to CMS, 2019-2025
47 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,126 · 2020: $408 · 2021: $190 · 2022: $434 · 2023: $515 · 2024: $411 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,290 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.56 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $481.43 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $313.84 | 2019-2024 | Stiolto Respimat |
| Amgen INC. | $283.87 | 2019-2025 | Otezla, Repatha, Krystexxa |
| Sanofi-Aventis U.S. LLC | $277.34 | 2019-2020 | |
| Lilly USA, LLC | $264.24 | 2019-2025 | Mounjaro, Zepbound, Amyvid |
| Astrazeneca Pharmaceuticals LP | $237.56 | 2019-2025 | Farxiga, Airsupra |
| Novartis Pharmaceuticals Corporation | $222.49 | 2019-2024 | |
| Pfizer INC. | $202.78 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $171.01 | 2019 | |
| Abbvie INC. | $163.02 | 2021-2024 | |
| Sunovion Pharmaceuticals INC. | $133.24 | 2019-2020 | |
| Glaxosmithkline, LLC. | $123.05 | 2019-2020 | |
| Medtronic, INC. | $110.74 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Merck Sharp & Dohme LLC | $104.43 | 2019-2025 | Capvaxive |
| Amarin Pharma, INC. | $97.61 | 2019-2021 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Liebowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.